Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Serum amyloid beta protein in young and elderly depression: a pilot study.

Kita Y, Baba H, Maeshima H, Nakano Y, Suzuki T, Arai H.

Psychogeriatrics. 2009 Dec;9(4):180-5. doi: 10.1111/j.1479-8301.2009.00293.x.

2.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
3.

Metabolism of amyloid-β protein may be affected in depression.

Baba H, Nakano Y, Maeshima H, Satomura E, Kita Y, Suzuki T, Arai H.

J Clin Psychiatry. 2012 Jan;73(1):115-20. doi: 10.4088/JCP.10m06766.

PMID:
22152118
4.

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

Mehta PD, Pirttilä T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM.

Arch Neurol. 2000 Jan;57(1):100-5.

PMID:
10634455
5.

Elevation in plasma Abeta42 in geriatric depression: a pilot study.

Pomara N, Doraiswamy PM, Willoughby LM, Roth AE, Mulsant BH, Sidtis JJ, Mehta PD, Reynolds CF 3rd, Pollock BG.

Neurochem Res. 2006 Mar;31(3):341-9.

PMID:
16583267
6.

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

Blennow K, De Meyer G, Hansson O, Minthon L, Wallin A, Zetterberg H, Lewczuk P, Vanderstichele H, Vanmechelen E, Kornhuber J, Wiltfang J; KND-Study Group., Heuser I, Maier W, Luckhaus C, Rüther E, Hüll M, Jahn H, Gertz HJ, Frölich L, Hampel H, Pernetzki R.

J Nutr Health Aging. 2009 Mar;13(3):205-8.

PMID:
19262954
7.

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC.

Arch Neurol. 2003 Jul;60(7):958-64.

PMID:
12873852
8.

Increased amyloid beta protein levels in children and adolescents with Down syndrome.

Mehta PD, Capone G, Jewell A, Freedland RL.

J Neurol Sci. 2007 Mar 15;254(1-2):22-7.

PMID:
17275850
9.

Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.

Xu W, Kawarabayashi T, Matsubara E, Deguchi K, Murakami T, Harigaya Y, Ikeda M, Amari M, Kuwano R, Abe K, Shoji M.

Brain Res. 2008 Jul 11;1219:169-79. doi: 10.1016/j.brainres.2008.02.060.

PMID:
18534566
10.

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.

Qiu WQ, Sun X, Selkoe DJ, Mwamburi DM, Huang T, Bhadela R, Bergethon P, Scott TM, Summergrad P, Wang L, Rosenberg I, Folstein M.

Int J Geriatr Psychiatry. 2007 Jun;22(6):536-42.

PMID:
17096467
11.

[A consideration for the mechanism of the transition from depression to dementia].

Baba H.

Seishin Shinkeigaku Zasshi. 2010;112(10):1003-8. Review. Japanese.

PMID:
21179663
12.

Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Aβ protein metabolism.

Namekawa Y, Baba H, Maeshima H, Nakano Y, Satomura E, Takebayashi N, Nomoto H, Suzuki T, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:203-8. doi: 10.1016/j.pnpbp.2012.12.016.

PMID:
23276885
13.

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K.

Dement Geriatr Cogn Disord. 2007;23(5):316-20.

PMID:
17374949
14.

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM.

Neurology. 2006 Jan 10;66(1):23-9.

PMID:
16401840
15.

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease.

Schupf N, Tang MX, Fukuyama H, Manly J, Andrews H, Mehta P, Ravetch J, Mayeux R.

Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14052-7. doi: 10.1073/pnas.0805902105.

16.

Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals.

Lee YH, Martin JM, Maple RL, Tharp WG, Pratley RE.

Neuroendocrinology. 2009;90(4):383-90. doi: 10.1159/000235555.

PMID:
19672057
17.

Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment.

Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro M, Vitali A, Bracco L, Caltagirone C, Bossù P, Odetti P, Tabaton M.

J Alzheimers Dis. 2009;18(2):267-71. doi: 10.3233/JAD-2009-1144.

PMID:
19584444
18.

Plasma amyloid beta protein 1-42 levels are increased in old Down Syndrome but not in young Down Syndrome.

Mehta PD, Mehta SP, Fedor B, Patrick BA, Emmerling M, Dalton AJ.

Neurosci Lett. 2003 May 22;342(3):155-8.

PMID:
12757888
19.

Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease.

Sun X, Mwamburi DM, Bungay K, Prasad J, Yee J, Lin YM, Liu TC, Summergrad P, Folstein M, Qiu WQ.

Biol Psychiatry. 2007 Dec 15;62(12):1413-7.

PMID:
17544381
20.

Serum creatinine levels correlate with plasma amyloid Beta protein.

Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR.

Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):187-90.

PMID:
12218650
Items per page

Supplemental Content

Support Center